The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
talking about for example uh sulforaphane protecting cultured neural cells from the toxicity of methylglyoxal which is a precursor of ages or advanced glycation end products that are very clearly associated with alzheimer's disease models that show reduced neuronal cell death due to amyloid beta exposure due to activation of peroxisomes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.